Find Research Projects

Search results

• A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Daily Oral Fasiglifam 25 mg and 50 mg Compared to Placebo When Used in Combination with Sitagliptin in Subjects with Type with Type 2 Diabetes

  Filipetto, F.

  Takeda Global Research and Dev Ctr

  26/09/13 → 28/02/19

  Project: Research

• A Randomized, Double-Blind, Active Controlled Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Children

  Fling, J.

  MedImmune, LLC

  8/03/10 → 31/03/11

  Project: Research

• A Prospective Study of Drinking &Academic Performace

  Thombs, D., THOMBS, D. L. & THOMBS, D. L.

  National Institute on Alcohol Abuse and Alcoholism

  1/08/04 → 31/07/07

  Project: Research

• A Prospective Study of Drinking &Academic Performace

  THOMBS, D. & Thombs, D.

  1/08/04 → 31/07/05

  Project: Research

• A Prospective, Single Arm, Open-Label Phase 2 Study to Characterize the Safety and Hemostatic Actifity of Topical Firocaps in Surgical Hemostasis

  Yurvati, A.

  ProFibrix

  6/07/10 → 31/08/13

  Project: Research

• A Prospective, Randomized, Double-blind, Phase II Study to Evaluate the Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis durning Vascular, Parenchymous, Soft Tissue, and Spinal Open Surgeries

  Yurvati, A.

  Grifols, Inc

  2/05/14 → 31/05/19

  Project: Research

• A Prospective, Randomized, Controlled Study to Evaluate the Effectiveness and Safety of CELSTAT as an Adjunct to Hemostasis for Tissue Bleeding in Cardiothoracic, General and Vascular Surgery

  Yurvati, A.

  Baxter Healthcare Corporation

  8/08/16 → 7/08/21

  Project: Research

• A Propsective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis during Peripheral Vascular Surgery

  Yurvati, A.

  Grifols, Inc

  18/02/15 → 28/02/20

  Project: Research

• A Pro-Inflammatory Endophenotype to Predict Treatment Response to NSAID Therapy in AD

  O'Bryant, S., Hall, J. & Johnson, L.

  NIA: National Institute on Aging

  1/09/16 → 31/03/21

  Project: Research

• A Proinflammatory Endophenotype to Predict NSAID Treatment Response Alzheimer's Disease Clinical Trials

  RISSMAN, R., LYKETSOS, C. & O'Bryant, S.

  1/09/16 → 31/03/21

  Project: Research

• A Proinflammatory Endophenotype to Predict NSAID Treatment Response Alzheimer's Disease Clinical Trials

  O'Bryant, S., LYKETSOS, C., RISSMAN, R., O'Bryant, S. & O'BRYANT, S.

  National Institute on Aging

  1/09/16 → 31/03/21

  Project: Research

• Application for Funding to Support the National Missing and Unidentified Persons System (NamUs)

  Budowle, B. & Coble, M.

  NIJ: National Institute of Justice

  1/10/16 → 30/09/20

  Project: Research

• Application for Funding to Support the National Missing and Unidentified Persons System (NamUs)

  Budowle, B. & Planz, J.

  NIJ: National Institute of Justice

  1/10/16 → 30/09/18

  Project: Research

• A Pilot Study on Impact of RTA405 on Glomerular Filtration Rate (GFR) in Type II Diabetic Rats: Phase I

  Ma, R.

  Reata Pharmaceuticals, Inc.

  1/07/11 → 30/09/12

  Project: Research

• A Phase Stratified, Randomized, Double-blind,Multicenter, Non-inferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quardavalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus in Subjects Ages

  Fling, J.

  Novartis Pharmaceuticals

  30/10/13 → 31/10/18

  Project: Research

• A Phase IV, Open-Label Administration (The Trial Statistician and Laboratory Technicians will be Blinded to Group Assignment), Randomized (Group 1 and 2), Parallel-Group, Multicenter Trial to Evaluate the Immunogenicity and Safety of 2 Doses of

  Fling, J.

  Sanofi Pasteur, Inc.

  3/08/12 → 31/08/15

  Project: Research

• "A PHASE Ill, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF CRENEZUMAB IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER'S DISEASE"

  Knebl, J.

  Hoffmann-La Roche Inc.

  18/08/16 → 17/08/21

  Project: Research

• A Phase III Stratified, Remdomized, Observer Blind, Controlled, Multicenter Clinical Study to Evaluate the Safety, Immumogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-adjuvanted Comparator

  Fling, J.

  Novartis Pharmaceuticals

  28/10/14 → 31/10/19

  Project: Research

• A Phase III Randomized, Partially Double-Blind, Active-Comparator Controlled, Lot-to-Lot Consistnecy Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V419 in Health Infants When Given at 2,4, and 6 Months Concomitantly with P

  Fling, J. & Habiba, N.

  Merck Co.

  1/07/11 → 22/05/15

  Project: Research

• A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with reduced Ejection Fraction (HFrEF).

  Kline, G.

  Boehringer Ingelheim International GmbH

  25/04/17 → 24/04/21

  Project: Research

• A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF).

  Kline, G.

  Boehringer Ingelheim International GmbH

  25/04/17 → 24/04/21

  Project: Research

• A Phase IIIA, Blinded, Randomized, Controlled. Multinational, Consistency Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' MMR Vaccine,(209762) Compared to Merck & Co., Inc.'s MMR Vaccine as a First

  Fling, J.

  GlaxoSmithKline

  8/10/13 → 31/10/18

  Project: Research

• A Phase III, Randomised, Multicenter Study, Double-Blind for the Immunogenicity and Consistency Evaluation of 3 Lots of GSK Biologicals' Haemophilus Influenzae Type b (Hib) Conjugate Vaccine and Single-Blind and Controlled for the Evaluation of Safety an

  Fling, J. & Habiba, N.

  GlaxoSmithKline

  22/02/10 → 15/01/13

  Project: Research

• A Phase II, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Investigate the Efficacy and Safety of RO4602522 Added to Background Alzheimer¿s Disease Therapy in Patients with Moderate Severity Alzheimer¿s Disease

  Knebl, J.

  Hoffmann-La Roche Inc.

  25/10/13 → 31/03/19

  Project: Research

• A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers > 12 cm2 to ¿ 36 cm2.

  Yurvati, A.

  Smith and Nephew

  28/02/13 → 1/03/16

  Project: Research

• A Phase 3 Multicenter, Double-blind, Randomized, Active Comparator-controlled, Clinical Trial to Evaluate the Safety and Efficacy of Doravirine (MK-1439) 100mg Once Daily Versus Darunavir 800 mg Once Daily plus Ritonavir 100mg Once Daily,

  Clay, P.

  Merck Co.

  19/12/14 → 31/12/20

  Project: Research

• A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (ABB-001, ELN115727) in Subjects with Alzheimer's Disease who Participated in Study ELN115727-301 or in Study ELN115727-302

  Knebl, J.

  Janssen Pharmaceuticals

  4/05/10 → 31/12/13

  Project: Research

• A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Long-term Safety and Tolerability of PF-04950615 in Subjects with Primary Hyperlipidemia or Mixed Dyslipdemia at Risk of Cardiovascular Events

  Kline, G.

  Pfizer, Inc.

  17/03/15 → 31/03/20

  Project: Research

• A Phase 3, Randomized, Single-blind, Controlled Trial of Topical Fibrocaps in Intraoperative Surgical Hemostasis

  Yurvati, A.

  ProFibrix

  1/05/12 → 31/08/15

  Project: Research

• A PHASE 3, PLACEBO CONTROLLED, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER

  Fling, J.

  Pfizer, Inc.

  13/04/17 → 13/04/21

  Project: Research

• A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E ¿4 Non-Carriers

  Knebl, J.

  Pfizer, Inc.

  14/11/11 → 30/11/15

  Project: Research

• A Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants

  Fling, J.

  MedImmune, LLC

  8/11/16 → 7/11/21

  Project: Research

• A Phase 1 Study Investigating Survival of HP802-247 Allogenic Cells in Excisional Acute Cutaneous Wounds

  Planz, J.

  Healthpoint, Ltd.

  1/09/10 → 31/12/10

  Project: Research

• AP4A IN CELL PROLIFERATION, DNA REPLICATION AND REPAIR

  Vishwanatha, J.

  6/07/91 → 30/06/95

  Project: Research

• AP4A IN CELL PROLIFERATION, DNA REPLICATION AND REPAIR

  Vishwanatha, J.

  National Institute of General Medical Sciences

  6/07/91 → 30/06/95

  Project: Research

• AP 1--AN ESTROGEN AND GLUCOCORTICOID INTEGRATOR

  Uht, R.

  National Institute of Diabetes and Digestive and Kidney Diseases

  23/08/95 → 31/07/01

  Project: Research

• AP 1--AN ESTROGEN AND GLUCOCORTICOID INTEGRATOR

  Uht, R. & Uht, R.

  23/08/95 → 31/07/01

  Project: Research

• Anti-Neuropilin Conjugated Theranostic Hybrid Nanoparticles Co-Encapsulating Curcumin and Methlyene Blue for Combinatorial Therapy of Glioblastoma

  Ranjan, A. & Yang, S.

  Intramural Research(UNTHSC)

  1/09/13 → 31/08/15

  Project: Research

• Anti-Inflammatory Effects of Pyruvate - Fortified Resuscitation in Pulmonary Tissue During Hypoxia with TCOM Student Charla Baker

  Yurvati, A.

  Intramural Research(UNTHSC)

  1/09/13 → 31/12/14

  Project: Research

• Anti-Inflammatory Effects of Pyruvate - Fortified Resuscitation in Pulmonary Tissue During Hypoxia with TCOM Student Charla Baker

  Mallet, R.

  Intramural Research(UNTHSC)

  1/09/13 → 31/12/14

  Project: Research

• ANTI INFARCTION EFFECTS IN THE DENERVATED HEART

  Gwirtz, P., Jones, C. & Jones, C.

  1/04/85 → 30/06/96

  Project: Research

• ANTI INFARCTION EFFECTS IN THE DENERVATED HEART

  Gwirtz, P., Jones, C., Jones, C. & Jones, C.

  National Institutes of Health, National Heart, Lung, and Blood Institute

  31/12/89 → 30/06/96

  Project: Research

• Antibiotics Discovery from the Great Lakes

  Cheng, Y. & CHENG, Y.

  National Institute of Allergy and Infectious Diseases

  1/07/07 → 30/06/10

  Project: Research

• Antibiotics Discovery from the Great Lakes

  Cheng, Y.

  1/07/07 → 30/06/10

  Project: Research

• Anti-Angiogenic Effect of Curcumin on Obesity-Related Inflammation and Oxidative Stress in Middle-Aged C57BL/6 Mice

  Filipetto, F., Franks, S., Forster, M. & Sumien, N.

  Intramural Research(UNTHSC)

  15/01/12 → 14/01/13

  Project: Research

• A Novel Prodrug Approach to Deliver TRH into the Brain

  Prokai-Tatrai, K.

  Intramural Research(UNTHSC)

  1/03/15 → 31/08/17

  Project: Research

• A Novel Pathogenic Pathway for Diabetic Keratopathy

  Karamichos, D., Ma, J. X., KARAMICHOS, D. & Ma, J. X.

  National Eye Institute

  1/09/18 → 31/08/21

  Project: Research

• A Novel Pathogenic Pathway for Diabetic Keratopathy

  Ma, J. X. & Karamichos, D.

  1/09/18 → 31/08/21

  Project: Research

• A Novel Nonparametric Threshold Free Method in Produce fMR1 Activation Maps Using Minimum Misclassification Rate

  Nandy, R.

  University of Maryland, Baltimore

  1/12/17 → 31/12/18

  Project: Research

• A Novel Neuroprotective Approach for Glaucoma

  Prokai-Tatrai, K.

  NEI: National Eye Institute

  1/08/16 → 31/07/21

  Project: Research